<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 17 Aug 2026 08:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;D&lt;/em&gt;&lt;em&gt;ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HOUSTON, Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;Second Quarter and First Half 2026 Financial Summary&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;margin-top:10pt; text-align:justify;&quot;&gt;Total revenues of approximately $1.77 million and $3.07 million for the second quarter 2026 and first half of 2026, respectively, were each up in excess of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;D&lt;/em&gt;&lt;em&gt;ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HOUSTON, Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;Second Quarter and First Half 2026 Financial Summary&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;margin-top:10pt; text-align:justify;&quot;&gt;Total revenues of approximately $1.77 million and $3.07 million for the second quarter 2026 and first half of 2026, respectively, were each up in excess of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;D&lt;/em&gt;&lt;em&gt;ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HOUSTON, Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;Second Quarter and First Half 2026 Financial Summary&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;margin-top:10pt; text-align:justify;&quot;&gt;Total revenues of approximately $1.77 million and $3.07 million for the second quarter 2026 and first half of 2026, respectively, were each up in excess of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;D&lt;/em&gt;&lt;em&gt;ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HOUSTON, Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;Second Quarter and First Half 2026 Financial Summary&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;margin-top:10pt; text-align:justify;&quot;&gt;Total revenues of approximately $1.77 million and $3.07 million for the second quarter 2026 and first half of 2026, respectively, were each up in excess of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nuo+Therapeutics+Announces+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935072.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  8-K        Nuo Therapeutics, Inc.    For: Aug 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Aug+17/26934956.html</link>
   <description>si-local-file:///var/storage/secattach/20260817/26934956.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Aug+17/26934956.html</guid>
   <pubDate>Mon, 17 Aug 2026 07:55:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  8-K        Nuo Therapeutics, Inc.    For: Aug 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Aug+17/26934956.html</link>
   <description>si-local-file:///var/storage/secattach/20260817/26934956.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Aug+17/26934956.html</guid>
   <pubDate>Mon, 17 Aug 2026 07:55:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  10-Q       Nuo Therapeutics, Inc.    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+30/26932665.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26932665.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+30/26932665.html</guid>
   <pubDate>Fri, 14 Aug 2026 17:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  10-Q       Nuo Therapeutics, Inc.    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+30/26932665.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26932665.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+30/26932665.html</guid>
   <pubDate>Fri, 14 Aug 2026 17:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: CLAUSEN PETER</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+CLAUSEN+PETER/26730287.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730287.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+CLAUSEN+PETER/26730287.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: CLAUSEN PETER</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+CLAUSEN+PETER/26730287.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730287.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+CLAUSEN+PETER/26730287.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+JORDEN+DAVID+EMERSON/26730258.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730258.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+JORDEN+DAVID+EMERSON/26730258.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+JORDEN+DAVID+EMERSON/26730258.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730258.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+JORDEN+DAVID+EMERSON/26730258.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: Pittman Scott M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Pittman+Scott+M./26730254.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730254.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Pittman+Scott+M./26730254.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: Pittman Scott M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Pittman+Scott+M./26730254.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730254.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Pittman+Scott+M./26730254.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: WINZER C ERIC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+WINZER+C+ERIC/26730250.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730250.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+WINZER+C+ERIC/26730250.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: WINZER C ERIC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+WINZER+C+ERIC/26730250.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730250.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+WINZER+C+ERIC/26730250.html</guid>
   <pubDate>Thu, 02 Jul 2026 21:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: Mintz Paul</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Mintz+Paul/26730249.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730249.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Mintz+Paul/26730249.html</guid>
   <pubDate>Thu, 02 Jul 2026 20:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 29  Filed by: Mintz Paul</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Mintz+Paul/26730249.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26730249.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+29++Filed+by%3A+Mintz+Paul/26730249.html</guid>
   <pubDate>Thu, 02 Jul 2026 20:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 05  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+05++Filed+by%3A+JORDEN+DAVID+EMERSON/26612520.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26612520.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+05++Filed+by%3A+JORDEN+DAVID+EMERSON/26612520.html</guid>
   <pubDate>Fri, 05 Jun 2026 18:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: Jun 05  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+05++Filed+by%3A+JORDEN+DAVID+EMERSON/26612520.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26612520.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+Jun+05++Filed+by%3A+JORDEN+DAVID+EMERSON/26612520.html</guid>
   <pubDate>Fri, 05 Jun 2026 18:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  Nuo Therapeutics, Inc.                 Filed by: Pittman Scott M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Nuo+Therapeutics%2C+Inc.+++++++++++++++++Filed+by%3A+Pittman+Scott+M./26597220.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26597220.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Nuo+Therapeutics%2C+Inc.+++++++++++++++++Filed+by%3A+Pittman+Scott+M./26597220.html</guid>
   <pubDate>Wed, 03 Jun 2026 11:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  Nuo Therapeutics, Inc.                 Filed by: Pittman Scott M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Nuo+Therapeutics%2C+Inc.+++++++++++++++++Filed+by%3A+Pittman+Scott+M./26597220.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26597220.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Nuo+Therapeutics%2C+Inc.+++++++++++++++++Filed+by%3A+Pittman+Scott+M./26597220.html</guid>
   <pubDate>Wed, 03 Jun 2026 11:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  8-K        Nuo Therapeutics, Inc.    For: May 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29/26594659.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26594659.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29/26594659.html</guid>
   <pubDate>Wed, 03 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  8-K        Nuo Therapeutics, Inc.    For: May 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29/26594659.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26594659.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29/26594659.html</guid>
   <pubDate>Wed, 03 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
  <item>
   <title>Form  4          Nuo Therapeutics, Inc.    For: May 29  Filed by: Pittman Scott M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29++Filed+by%3A+Pittman+Scott+M./26594114.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26594114.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuo+Therapeutics%2C+Inc.++++For%3A+May+29++Filed+by%3A+Pittman+Scott+M./26594114.html</guid>
   <pubDate>Tue, 02 Jun 2026 21:55:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AURX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00646918</category>
   	  </item>
 </channel>
</rss>
